Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604.

Article  PubMed  PubMed Central  Google Scholar 

Yu LX, Schwabe RF. The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol. 2017;14(9):527–39.

Article  PubMed  PubMed Central  Google Scholar 

Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681–93.

Article  PubMed  Google Scholar 

Famularo S, Donadon M, Cipriani F, Giuliante F, Ferri S, Celsa C, et al. Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma. Ann Surg. 2022;275(4):743–52.

Article  PubMed  Google Scholar 

Liu ZH, Sun JX, Feng JK, Yang SY, Chen ZH, Liu C, et al. Prognostic comparison between liver resection and transcatheter arterial chemoembolization for Hepatocellular Carcinoma patients with bile Duct Tumor Thrombus: a propensity-score matching analysis. Front Oncol. 2022;12:835559.

Article  PubMed  PubMed Central  Google Scholar 

Tustumi F, Coelho FF, de Paiva Magalhães D, Júnior SS, Jeismann VB, Fonseca GM et al. Treatment of hepatocellular carcinoma with macroscopic vascular invasion: a systematic review and network meta-analysis. Transplantation Reviews. 2023;37(3).

Gao Y, Wang PX, Cheng JW, Sun YF, Hu B, Guo W, et al. Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: a propensity score-matched survival analysis. Cancer Med. 2019;8(16):6933–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim D-S, Kim B-W, Hatano E, Hwang S, Hasegawa K, Kudo A, et al. Surgical outcomes of Hepatocellular Carcinoma with bile Duct Tumor Thrombus. Ann Surg. 2020;271(5):913–21.

Article  PubMed  Google Scholar 

Liu F, Guo X, Dong W, Zhang W, Wei S, Zhang S, et al. Postoperative adjuvant TACE-associated nomogram for predicting the prognosis of resectable Hepatocellular Carcinoma with portal vein tumor Thrombus after liver resection. Int J Biol Sci. 2020;16(16):3210–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wong TCL, Cheung TT, Chok KSH, Chan ACY, Dai WC, Chan SC, et al. Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus. Hpb. 2015;17(5):401–8.

Article  PubMed  Google Scholar 

Yang X, Zhu Y, Zhao X, Li JH, Xu D, Jia HL, et al. The Prognostic Comparison between Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and bile Duct Cancer Thrombus after liver resection. Cancer Manag Res. 2020;12:12077–86.

Article  PubMed  PubMed Central  Google Scholar 

Ding Y, Shaohua L, Qiaoxuan W, Peng S, Qing L, Zhongyuan Y et al. Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic vein Tumor thrombosis. PLoS ONE. 2015;10(6).

Feng J-K, Wu Y-X, Chen Z-H, Sun J-X, Wang K, Chai Z-T, et al. The effect of bile duct tumor thrombus on the long-term prognosis of hepatocellular carcinoma patients after liver resection: a systematic review and meta-analysis. Annals Translational Med. 2020;8(24):1683.

Article  CAS  Google Scholar 

Huo L, Wei W, Yan Z, Lei Z, Xie Y, Gong R, et al. Short-term and long-term outcomes of liver resection for HCC patients with portal vein tumor thrombus. Cell Biosci. 2019;9:23.

Article  PubMed  PubMed Central  Google Scholar 

Zhang XP, Wang K, Gao YZ, Wei XB, Lu CD, Chai ZT, et al. Prognostic model for identifying candidates for hepatectomy among patients with hepatocellular carcinoma and hepatic vein invasion. Br J Surg. 2020;107(7):865–77.

Article  PubMed  Google Scholar 

Zhang Y, Wu J-L, Li L-Q. Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombus. Ann Hepatol. 2022;27(1).

Qi LN, Ma L, Wu FX, Chen YY, Xu JX, Peng YC, et al. Clinical implications and biological features of a novel postoperative recurrent HCC classification: a multi-centre study. Liver Int. 2022;42(10):2283–98.

Article  CAS  PubMed  Google Scholar 

Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–80.

Article  PubMed  PubMed Central  Google Scholar 

Xu JX, Qin SL, Wei HW, Chen YY, Peng YC, Qi LN. Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization. Ann Med. 2023;55(1):2199219.

Article  PubMed  PubMed Central  Google Scholar 

Abdou AG, Holah NS, Elazab DS, El-Gendy WG, Badr MT, Al-Sharaky DR. Hepatocellular Carcinoma Score and subclassification into aggressive subtypes using immunohistochemical expression of p53, beta-catenin, CD133, and Ki-67. Appl Immunohistochem. 2021;29(1):20–33.

CAS  Google Scholar 

Kim BW, Kim YB, Wang HJ, Kim MW. Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma. World J Gastroenterol. 2006;12(1):99–104.

Article  PubMed  PubMed Central  Google Scholar 

Li J, Huang L, Liu C, Qiu M, Yan J, Yan Y, et al. Risk factors and clinical outcomes of extrahepatic recurrence in patients with post-hepatectomy recurrent hepatocellular carcinoma. ANZ J Surg. 2021;91(6):1174–9.

Article  PubMed  Google Scholar 

Pan C, Liu X, Zou B, Chin W, Zhang W, Ye Y, et al. A Nomogram Estimation for the risk of Microvascular Invasion in Hepatocellular Carcinoma patients Meeting the Milan Criteria. J Invest Surg. 2022;35(3):535–41.

Article  PubMed  Google Scholar 

Takeishi K, Maeda T, Tsujita E, Yamashita YI, Harada N, Itoh S, et al. Predictors of Intrahepatic multiple recurrences after curative hepatectomy for Hepatocellular Carcinoma. Anticancer Res. 2015;35(5):3061–6.

PubMed  Google Scholar 

Yan Y, Zhou Q, Zhang M, Liu H, Lin J, Liu Q, et al. Integrated Nomograms for Preoperative Prediction of Microvascular Invasion and Lymph Node Metastasis Risk in Hepatocellular Carcinoma patients. Ann Surg Oncol. 2020;27(5):1361–71.

Article  PubMed  Google Scholar 

Wen T, Jin C, Facciorusso A, Donadon M, Han HS, Mao Y, et al. Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus. Hepatobiliary Surg Nutr. 2018;7(5):353–71.

Article  PubMed  PubMed Central  Google Scholar 

Zhou J, Sun H, Wang Z, Cong W, Zeng M, Zhou W, et al. Guidelines for the diagnosis and treatment of primary Liver Cancer (2022 Edition). Liver Cancer. 2023;12(5):405–44.

Article  PubMed  PubMed Central  Google Scholar 

Cheng YC, Chen TW, Fan HL, Yu CY, Chang HC, Hsieh CB. Transarterial chemoembolization for intrahepatic multiple recurrent HCC after liver resection or transplantation. Ann Transplant. 2014;19:309–16.

Article  CAS  PubMed  Google Scholar 

He J, Zeng ZC, Tang ZY, Fan J, Zhou J, Zeng MS, et al. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy. Cancer. 2009;115(12):2710–20.

Article  PubMed  Google Scholar 

Oh D, Lim DH, Park HC, Paik SW, Koh KC, Lee JH, et al. Early three-dimensional conformal radiotherapy for patients with unresectable hepatocellular carcinoma after incomplete transcatheter arterial chemoembolization: a prospective evaluation of efficacy and toxicity. Am J Clin Oncol. 2010;33(4):370–5.

Article  CAS  PubMed  Google Scholar 

Menon SS, Guruvayoorappan C, Sakthivel KM, Rasmi RR. Ki-67 protein as a tumour proliferation marker. Clin Chim Acta. 2019;491:39–45.

Article  CAS  PubMed  Google Scholar 

Rahmanzadeh R, Huttmann G, Gerdes J, Scholzen T. Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis. Cell Prolif. 2007;40(3):422–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng JN, Ma TX, Cao JY, Sun XQ, Chen JC, Li W, et al. Knockdown of Ki-67 by small interfering RNA leads to inhibition of proliferation and induction of apoptosis in human renal carcinoma cells. Life Sci. 2006;78(7):724–9.

Article  CAS  PubMed